ArticleAntimicrobial agents and chemotherapy2014

Combination of the CCL5-derived peptide R4.0 with different HIV-1 blockers reveals wide target compatibility and synergic cobinding to CCR5.

Massimiliano Secchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.